| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Pediatrics (L.G., A.V., M.F.) and Department of Obstetrics and Gynecology (B.F.), University of Parma, 43100 Parma, Italy; Department of Endocrinology and Metabolism (A.B., A.C.), University of Genova, 16132 Genova, Italy; Evgenidion Hospital (G.M.), Athens University, Medical School, Endocrine Unit, 11528 Athens, Greece; National Institute of Child Health and Human Development (G.P.C.), National Institutes of Health, Bethesda, Maryland 20892; and Department of Pediatrics (S.B.), University of Modena, 41100 Modena, Italy
Address all correspondence and requests for reprints to: Lucia Ghizzoni, M.D., Department of Pediatrics, University of Parma, Via Gramsci 14, 43100 Parma, Italy. E-mail: lughizzo{at}ipruniv.cce.unipr.it
The presence of immunoreactive CRH was recently demonstrated in human
ovaries. CRH immunoreactivity was localized by immunohistochemistry in
the cytoplasm of thecal cells surrounding the ovarian follicles, in
luteinized cells of the stroma, and in large granulosa-derived
luteinized cells of developing corpora lutea. Also, CRH and its
receptors were identified in Leydig cells of the testis where CRH was
shown to inhibit testosterone biosynthesis. To examine the role of CRH
in the ovary, we studied its effect on estradiol (E2) and
progesterone (P4) release by human granulosa cells obtained
from women undergoing in vitro fertilization for male
factor infertility or uni- or bilateral tubal impatency. In all
subjects, superovulation was induced by treatment with gonadotropins.
The effects of graded doses of ovine CRH
(10-1110-6 mol/liter) were evaluated in the
conditioned medium obtained after 24 h incubation of the cells.
All CRH concentrations employed except for the lowest one
(10-11 mol/liter) caused a significant decrease of media
E2 and P4 levels. Maximal inhibition for both
E2 and P4 production was obtained by
10-6 mol/liter CRH concentration, which decreased hormone
production by 39% and 34%, respectively. The
-helical
CRH941 antagonist at 10-6 and
10-7 mol/liter blocked the suppressive effect of
10-9 mol/liter CRH on both E2 and
P4 secretion, while it had no effect when added to the
culture media without CRH. Since interleukin (IL-1)-1 mediates certain
actions of CRH on leukocytes, we examined whether the CRH effect on
ovarian steroidogenesis was IL-1-mediated. Interleukin-1 receptor
antagonist at 10-7 and 10-6 mol/liter blocked
the inhibitory effects of CRH on E2 and P4
secretion, while it had no effect in the absence of CRH. In conclusion,
CRH exerts a CRH- and IL-1 receptor-mediated inhibitory effect on
ovarian steroidogenesis and might be actively involved in the still
enigmatic processes of follicular atresia and luteolysis.
This article has been cited by other articles:
![]() |
J. Xu, F. Xu, J. D. Hennebold, T. A. Molskness, and R. L. Stouffer Expression and Role of the Corticotropin-Releasing Hormone/Urocortin-Receptor-Binding Protein System in the Primate Corpus Luteum during the Menstrual Cycle Endocrinology, November 1, 2007; 148(11): 5385 - 5395. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. NEPOMNASCHY, E. SHEINER, G. MASTORAKOS, and P. C. ARCK Stress, Immune Function, and Women's Reproduction Ann. N.Y. Acad. Sci., October 1, 2007; 1113(1): 350 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yang, X. You, X. Tang, L. Gao, and X. Ni Corticotropin-releasing hormone inhibits progesterone production in cultured human placental trophoblasts J. Mol. Endocrinol., December 1, 2006; 37(3): 533 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. VITORATOS, D. C. PAPATHEODOROU, S. N. KALANTARIDOU, and G. MASTORAKOS "Reproductive" Corticotropin-Releasing Hormone Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 310 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mastorakos, E. I Karoutsou, and M. Mizamtsidi Corticotropin releasing hormone and the immune/inflammatory response Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S77 - S84. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. You, R. Yang, X. Tang, L. Gao, and X. Ni Corticotropin-Releasing Hormone Stimulates Estrogen Biosynthesis in Cultured Human Placental Trophoblasts Biol Reprod, June 1, 2006; 74(6): 1067 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Nepomnaschy, K. B. Welch, D. S. McConnell, B. S. Low, B. I. Strassmann, and B. G. England Cortisol levels and very early pregnancy loss in humans PNAS, March 7, 2006; 103(10): 3938 - 3942. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. KALANTARIDOU, A. MAKRIGIANNAKIS, G. MASTORAKOS, and G. P. CHROUSOS Roles of Reproductive Corticotropin-Releasing Hormone Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 129 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Muramatsu, N. Sugino, T. Suzuki, K. Totsune, K. Takahashi, A. Tashiro, M. Hongo, Y. Oki, and H. Sasano Urocortin and Corticotropin-Releasing Factor Receptor Expression in Normal Cycling Human Ovaries J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1362 - 1369. [Abstract] [Full Text] |
||||
![]() |
G. MASTORAKOS and I. ILIAS Maternal Hypothalamic-Pituitary-Adrenal Axis in Pregnancy and the Postpartum Period: Postpartum-Related Disorders Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 95 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ferin Stress and the Reproductive Cycle J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1768 - 1774. [Full Text] |
||||
![]() |
J. A. McCracken, E. E. Custer, and J. C. Lamsa Luteolysis: A Neuroendocrine-Mediated Event Physiol Rev, April 1, 1999; 79(2): 263 - 323. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |